UNSPSC 85251511: Diagnosis of malignant neoplasm on the overlapping lesion of tongue

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Overlapping lesion of tongue. Malignant neoplasm on the Overlapping lesion of tongue is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C02. 8

UNSPSC 85251511 Diagnosis of malignant neoplasm on the overlapping lesion of tongue is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The three most recent state and local contract opportunities tagged under this code are diagnostic imaging infrastructure (a Picture Archiving and Communication System for San Mateo Medical Center), special education contracted services (Birdville Independent School District), and temporary health professional staffing (Santa Clara County Health System). None of these solicitations involve diagnosis of malignant neoplasm or oncology services; the code assignment appears to reflect a data entry or taxonomy misalignment rather than the work actually being procured.

The opportunities do not support a meaningful characterization of issuing bodies, geographic spread, or service patterns under this code. San Mateo County (California) is requesting PACS implementation with EPIC integration and 99.9% uptime support for approximately 65,000 annual radiology studies, due October 21, 2026; Birdville Independent School District (Texas) is requesting special education contracted services across 23 line items, due October 21, 2026; and Santa Clara County (California) is establishing a qualified vendor pool for temporary health professional staffing across thirteen ancillary clinical categories, due October 7, 2026. No recent opportunities indicate active procurement demand for oncologic diagnosis services under this code. Firms considering pursuit should verify code assignment with the issuing body before investing in proposal development.